Deleuze, FR
Anne-Laure Deleuze, Paris FR
Patent application number | Description | Published |
---|---|---|
20090147831 | METHOD OF MULTIPLE ACCESS COMMUNICATION IN A CENTRALIZED NETWORK BASED ON AN ULTRA WIDEBAND IMPULSE PHYSICAL LAYER - Method of multiple access communication in a centralized network based on an ultra wideband impulse physical layer allowing code-based multiple access, each user being associated with a code, the transmission being performed in an asynchronous manner in a propagation medium with multiple paths. It is characterized in that a criterion is established so as to find the codes of the Nu various users making it possible to minimize the variance of the multi-user interference J | 06-11-2009 |
Charles Deleuze, Monts FR
Patent application number | Description | Published |
---|---|---|
20090266823 | METHOD FOR MANUFACTURING A SEALING BLADDER MADE OF THERMOSETTING POLYMER FOR A TANK CONTAINING A PRESSURIZED FLUID, SUCH AS A COMPOSITE TANK, AND A TANK - A method for manufacturing a polymer bladder assuring the internal sealing of a tank vis-à-vis a pressurized fluid which is contained therein, wherein said polymer is a thermosetting polymer, and said method comprises at least one step of polymerizing at least two precursor compounds of said thermosetting polymer carried out in a mould in rotation. | 10-29-2009 |
20160023381 | METHOD FOR MANUFACTURING A SEALING BLADDER MADE OF THERMOSETTING POLYMER FOR A TANK CONTAINING A PRESSURIZED FLUID, SUCH AS A COMPOSITE TANK, AND A TANK - A method for manufacturing a polymer bladder assuring the internal sealing of a tank vis-à-vis a pressurized fluid which is contained therein, wherein said polymer is a thermosetting polymer, and said method comprises at least one step of polymerizing at least two precursor compounds of said thermosetting polymer carried out in a mould in rotation. | 01-28-2016 |
Gilles Deleuze, Paris FR
Patent application number | Description | Published |
---|---|---|
20150295578 | METHOD FOR THE RADIATION HARDENING OF AN ELECTRONIC CIRCUIT BY PARTITIONING - The method relates to a method for the radiation hardening of an electronic circuit by partitioning, said circuit including an odd number K of parallel branches connected to a same primary input I and each including a same series of N modules and N−1 nodes linking two consecutive modules, the K branches together forming a series of N−1 gates respectively consisting of parallel K nodes, and a primary arbiter forming a majority vote from the output signal of the K branches, the method being characterized in that it includes the following steps which are repeated for each one of the gates: determining a reliability of a subcircuit upstream from the gate consisting of the portions of the K branches located between the primary input and the gate, and the insertion of at least one arbiter at the gate forming a majority vote from the output signals of said portions of branches constituting the scanned subcircuit and outputting at least one majority signal to the respective inputs of an additional subcircuit formed by the branch portions downstream from the gate, if the reliability of the scanned subcircuit is less than a reliability set point. | 10-15-2015 |
Herve Deleuze, Saint Magne FR
Patent application number | Description | Published |
---|---|---|
20110130534 | HIGH-STRENGTH POLYHIPE MATERIAL, PROCESS FOR PREPARING THE SAME, EMULSION USEFUL FOR PREPARATION THEREOF AND ARTICLE FORMED OF SAID MATERIAL - The invention relates to a polyHIPE material provided with high mechanical strength, which material comprises at least one N-alkenyltriazole monomer and a cross-linking monomer in a weight ratio of cross-linking monomer/N-alkenyltriazole monomer of 1/100 to 60/100. | 06-02-2011 |
20130210094 | HETEROGENEOUS ENZYMATIC CATALYST, PROCESS FOR PREPARING SAME AND USE FOR CONTINUOUS FLOW ENZYMATIC CATALYSIS - The present invention relates to a heterogeneous enzymatic catalyst consisting of a macroprous silica monolith incorporating an enzyme immobilized by means of a compiling agent, to a process for preparing this enzymatic catalyst, to the use of the catalyst for carrying out chemical reactions by continuous flow heterogeneous enzymatic catalyst and to a process of continuous flow heterogeneous enzymatic catalysis using said catalyst. | 08-15-2013 |
Hervé Deleuze, Le Barp FR
Patent application number | Description | Published |
---|---|---|
20100166930 | PROCESS FOR EXTRACTING CARBONYLATED COMPOUNDS FROM A DRINK BY LIQUID-SOLID EXTRACTION WITH A FUNCTIONALIZED INERT SUPPORT - The present invention relates to a process for extracting carbonylated compounds from a drink by liquid-solid extraction with a functionalized inert support containing nitrogenous nucleophilic functional groups. Advantageously, according to the present invention, the drink is wine or fruit juice. The process according to the present invention is advantageously applied to the reduction of the sulphur dioxide combination capacity of a drink such as wine. | 07-01-2010 |
Hervé Deleuze, Le Barp FR
Patent application number | Description | Published |
---|---|---|
20100166930 | PROCESS FOR EXTRACTING CARBONYLATED COMPOUNDS FROM A DRINK BY LIQUID-SOLID EXTRACTION WITH A FUNCTIONALIZED INERT SUPPORT - The present invention relates to a process for extracting carbonylated compounds from a drink by liquid-solid extraction with a functionalized inert support containing nitrogenous nucleophilic functional groups. Advantageously, according to the present invention, the drink is wine or fruit juice. The process according to the present invention is advantageously applied to the reduction of the sulphur dioxide combination capacity of a drink such as wine. | 07-01-2010 |
Ivan Deleuze, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20160085732 | CHECKING LINKS - A method of checking links in a message comprises detecting the creation of a new message, detecting the presence of one or more links in the message, determining if each link is invalid, and highlighting each link that is determined to be invalid. The highlighting of each link that is determined to be invalid occurs as the message is created or when a send message request is received. | 03-24-2016 |
Jean-Francois Deleuze, Paris FR
Patent application number | Description | Published |
---|---|---|
20130330341 | SINGLE NUCLEOTIDE POLYMORPHISMS IN THE PROMOTER OF VEGFA GENE AND THEIR USE AS PREDICTIVE MARKERS FOR ANTI-VEGF TREATMENTS - The invention relates to the treatment and the diagnosis of a group of patients bearing specific alleles of single nucleotide polymorphisms in the promoter region of the VEGFA gene. These patients are more responsive to Aflibercept and more likely to be efficiently treated by anti-VEGF therapy. | 12-12-2013 |
Jean-Francois Deleuze, Evry FR
Patent application number | Description | Published |
---|---|---|
20080312098 | Use of a Gip Promoter Polymorphism - The use of the single nucleotide polymorphism (SNP) at position −(97) of the GIP gene for the identification of a cardiovascular disease or of an increased risk for developing a cardiovascular disease in a biological sample taken from an individual to be examined. | 12-18-2008 |
Jean-Francois Deleuze, Combs La Ville FR
Patent application number | Description | Published |
---|---|---|
20090239237 | METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM - The present invention is directed to a method identifying a risk for a thrombogenic disorder including, without limitation, atrial fibrillation, stroke, prolonged intermitted neurological deficit (PRIND), transitory ischemic attack (TIA), atherosclerotic cerebrovascular disease (CVD) and/or coronary heart disease, as well as to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism. | 09-24-2009 |
20100062431 | USE OF ADAMTS4 GENE AND PROTEIN POLYMORPHISMS - The use of the single nucleotide polymorphism (SNP) of the ADAMTS4 gene for the identification of cardiovascular and peripheral vascular disorders or of an increased risk for developing cardiovascular and peripheral vascular disorders in a biological sample taken from an individual to be examined; the use of ADAMTS4 for identifying substances active in preventing and/or treating cardiovascular and peripheral vascular disorders and methods for doing so. | 03-11-2010 |
20100221714 | ANALYSIS AND USE OF PAR1 POLYMORPHISMS FOR EVALUATING THE RISK OF CARDIOVASCULAR DISEASE - The invention relates to polynucleotide sequences comprising genetic variations of the PAR1 gene at positions 3090 and/or 3329. The occurrence of these variants in humans correlates with increased occurrence of particular cardiovascular disorders. The invention furthermore relates to methods for detecting said genetic variations for the purpose of patient diagnosis. | 09-02-2010 |
20100221738 | METHOD OF DIAGNOSIS OF A PREDISPOSITION TO DEVELOP THROMBOTIC DISEASE AND ITS USES - The present invention refers to a method of diagnosis of a predisposition to develop thrombotic disease, to test systems and their use for the diagnosis of a predisposition to develop thrombotic disease, to a P | 09-02-2010 |
20110104704 | ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF - The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject. | 05-05-2011 |
20110223628 | METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM - The present invention is directed to a method identifying a risk for a thrombogenic disorder including, without limitation, atrial fibrillation, stroke, prolonged intermitted neurological deficit (PRIND), transitory ischemic attack (TIA), atherosclerotic cerebrovascular disease (CVD) and/or coronary heart disease, as well as to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism. | 09-15-2011 |
20120208200 | ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF - The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject. | 08-16-2012 |